Global Beraprost Market Size, Share and Trends Analysis Report, By Type (20 ug Tablet and 40 ug Tablet), By Application (High Blood Pressure, Spinal Canal, Chronic Renal Failure, Peripheral Vascular Disease, Chronic Arterial Occlusive Disease, and Others), Forecast (2022-2028)

The global beraprost market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Beraprost is a pharmaceutical drug used in several Asian countries, including Japan and South Korea, as a vasodilator and antiplatelet agent for the treatment of pulmonary hypertension, and is classified as a prostacyclin analog. The major factor expected to drive the market is the rising incidences of hypertension. A study done by the World Health Organization (WHO) on a total of 116 Patients with functional class II or III primary pulmonary hypertension or PAH related to either collagen vascular diseases or congenital systemic to pulmonary shunts were enrolled and patients were randomized to receive the maximally tolerated dose of beraprost sodium (median dose 120 ug four times a day) or placebo for 12 months. The study shows that patients treated with beraprost exhibited less evidence of disease progression at six months (p = 0.002), however, this effect was not evident at either shorter or longer follow-up intervals.

Further, this study also shows that beraprost-treated patients had improved 6-min walk distance at 3 months by 22 m from baseline and at 6 months by 31 m (p = 0.010 and 0.016, respectively) compared with placebo, however, not at either 9 or 12 months. Some major players in the market include Astellas Pharma Inc., and Toray Industries Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

• Competitive Landscape– Astellas Pharma Inc., and Toray Industries Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Beraprost Market Report by Segment

By Type

• 20 ug Tablet
• 40 ug Tablet

By Application

• High Blood Pressure
• Spinal Canal
• Chronic Renal Failure
• Peripheral Vascular Disease
• Chronic Arterial Occlusive Disease
• Others

Global Beraprost Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa